Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Dr. Anu Sharman

Anu Sharman, Ph.D.

Dr. Anu Sharman manages a portfolio of grants focusing on genetic alterations associated with cancer health disparities, models for investigating cancer disparities, and drivers of genomic instability among racial/ethnic populations. Additionally, she manages R03, R15, and R50 applications related to DNA and chromosome aberrations.  

Research Programs

Dr. Sharman is also involved in a trans-NCI initiative:

Background

Dr. Sharman started her career in a Pharmacology laboratory at Georgetown University Medical Center where she tested pharmaceutical drugs on animal models. She also worked as a biologist at the National Science Foundation (NSF) for 8 years, where she managed a biological sciences portfolio.

Education

  • Ph.D., Business Administration, University of Maryland- Global Campus
  • M.S., Biology, Fordham University
  • Updated:
Email